Cargando…

The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study

BACKGROUND: A major event in the post-meiotic development of male germ cells is the formation of the acrosome. This process can be perturbed in C57BL/6 mice by administration of the small molecule miglustat (N-butyldeoxynojirimycin, NB-DNJ). The miglustat-treated mice produce morphologically abnorma...

Descripción completa

Detalles Bibliográficos
Autores principales: Bone, Wilhelm, Walden, Charlotte M, Fritsch, Martin, Voigtmann, Ulrike, Leifke, Eckhard, Gottwald, Ulrich, Boomkamp, Stephanie, Platt, Frances M, van der Spoel, Aarnoud C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794412/
https://www.ncbi.nlm.nih.gov/pubmed/17241468
http://dx.doi.org/10.1186/1477-7827-5-1
_version_ 1782132168360722432
author Bone, Wilhelm
Walden, Charlotte M
Fritsch, Martin
Voigtmann, Ulrike
Leifke, Eckhard
Gottwald, Ulrich
Boomkamp, Stephanie
Platt, Frances M
van der Spoel, Aarnoud C
author_facet Bone, Wilhelm
Walden, Charlotte M
Fritsch, Martin
Voigtmann, Ulrike
Leifke, Eckhard
Gottwald, Ulrich
Boomkamp, Stephanie
Platt, Frances M
van der Spoel, Aarnoud C
author_sort Bone, Wilhelm
collection PubMed
description BACKGROUND: A major event in the post-meiotic development of male germ cells is the formation of the acrosome. This process can be perturbed in C57BL/6 mice by administration of the small molecule miglustat (N-butyldeoxynojirimycin, NB-DNJ). The miglustat-treated mice produce morphologically abnormal spermatozoa that lack acrosomes and are poorly motile. In C57BL/6 mice, miglustat can be used to maintain long-term reversible infertility. In contrast, when miglustat was evaluated in normal men, it did not affect spermatogenesis. To gain more insight into this species difference we have now evaluated the reproductive effects of miglustat in rabbits, in multiple mouse strains and in interstrain hybrid mice. METHODS: Male mice of 18 inbred strains were administered miglustat orally or via miniosmotic pumps. Rabbits were given the compound in their food. Fourth-generation interstrain hybrid mice, bred from C57BL/6 and FVB/N mice (which differ in their response to miglustat), also received the drug. Data on fertility (natural mating), sperm motility and morphology, acrosome status, and serum drug levels were collected. RESULTS: In rabbits the drug did not induce aberrations of sperm shape or motility, although the serum level of miglustat in rabbits far exceeded the level in C57BL/6 mice (8.4 μM and 0.5 μM, respectively). In some strains of the Swiss and Castle lineages of inbred mice miglustat did not cause infertility, severe morphological sperm aberrations or reduced sperm motility. In these strains miglustat only had milder effects. However, miglustat strongly disturbed acrosome and sperm nucleus development in AKR/J and BALB/c mice and in a number of C57BL/6-related strains. The consequences of drug administration in the interstrain hybrid mice were highly variable. Judging by the number of grossly abnormal spermatozoa, these genetically heterogeneous mice displayed a continuous range of intermediate responses, distinct from either of their parental strains. CONCLUSION: The effects of miglustat on spermatogenesis in mice are strain-dependent, while in rabbits the drug is ineffective. Evaluation of interstrain hybrid mice indicated that the sensitivity of spermatogenesis to miglustat is a quantitative trait. These studies pave the way for identifying the genetic factors underlying the strain/species differences in the effect of miglustat.
format Text
id pubmed-1794412
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17944122007-02-08 The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study Bone, Wilhelm Walden, Charlotte M Fritsch, Martin Voigtmann, Ulrike Leifke, Eckhard Gottwald, Ulrich Boomkamp, Stephanie Platt, Frances M van der Spoel, Aarnoud C Reprod Biol Endocrinol Research BACKGROUND: A major event in the post-meiotic development of male germ cells is the formation of the acrosome. This process can be perturbed in C57BL/6 mice by administration of the small molecule miglustat (N-butyldeoxynojirimycin, NB-DNJ). The miglustat-treated mice produce morphologically abnormal spermatozoa that lack acrosomes and are poorly motile. In C57BL/6 mice, miglustat can be used to maintain long-term reversible infertility. In contrast, when miglustat was evaluated in normal men, it did not affect spermatogenesis. To gain more insight into this species difference we have now evaluated the reproductive effects of miglustat in rabbits, in multiple mouse strains and in interstrain hybrid mice. METHODS: Male mice of 18 inbred strains were administered miglustat orally or via miniosmotic pumps. Rabbits were given the compound in their food. Fourth-generation interstrain hybrid mice, bred from C57BL/6 and FVB/N mice (which differ in their response to miglustat), also received the drug. Data on fertility (natural mating), sperm motility and morphology, acrosome status, and serum drug levels were collected. RESULTS: In rabbits the drug did not induce aberrations of sperm shape or motility, although the serum level of miglustat in rabbits far exceeded the level in C57BL/6 mice (8.4 μM and 0.5 μM, respectively). In some strains of the Swiss and Castle lineages of inbred mice miglustat did not cause infertility, severe morphological sperm aberrations or reduced sperm motility. In these strains miglustat only had milder effects. However, miglustat strongly disturbed acrosome and sperm nucleus development in AKR/J and BALB/c mice and in a number of C57BL/6-related strains. The consequences of drug administration in the interstrain hybrid mice were highly variable. Judging by the number of grossly abnormal spermatozoa, these genetically heterogeneous mice displayed a continuous range of intermediate responses, distinct from either of their parental strains. CONCLUSION: The effects of miglustat on spermatogenesis in mice are strain-dependent, while in rabbits the drug is ineffective. Evaluation of interstrain hybrid mice indicated that the sensitivity of spermatogenesis to miglustat is a quantitative trait. These studies pave the way for identifying the genetic factors underlying the strain/species differences in the effect of miglustat. BioMed Central 2007-01-22 /pmc/articles/PMC1794412/ /pubmed/17241468 http://dx.doi.org/10.1186/1477-7827-5-1 Text en Copyright © 2007 Bone et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Bone, Wilhelm
Walden, Charlotte M
Fritsch, Martin
Voigtmann, Ulrike
Leifke, Eckhard
Gottwald, Ulrich
Boomkamp, Stephanie
Platt, Frances M
van der Spoel, Aarnoud C
The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study
title The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study
title_full The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study
title_fullStr The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study
title_full_unstemmed The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study
title_short The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study
title_sort sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794412/
https://www.ncbi.nlm.nih.gov/pubmed/17241468
http://dx.doi.org/10.1186/1477-7827-5-1
work_keys_str_mv AT bonewilhelm thesensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT waldencharlottem thesensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT fritschmartin thesensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT voigtmannulrike thesensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT leifkeeckhard thesensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT gottwaldulrich thesensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT boomkampstephanie thesensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT plattfrancesm thesensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT vanderspoelaarnoudc thesensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT bonewilhelm sensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT waldencharlottem sensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT fritschmartin sensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT voigtmannulrike sensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT leifkeeckhard sensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT gottwaldulrich sensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT boomkampstephanie sensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT plattfrancesm sensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy
AT vanderspoelaarnoudc sensitivityofmurinespermiogenesistomiglustatisaquantitativetraitapharmacogeneticstudy